Palomar (NASDAQ:PLMR) COO Rodolphe Herve Sells 425 Shares of Stock

Palomar Holdings, Inc. (NASDAQ:PLMR) COO Rodolphe Herve sold 425 shares of the company’s stock in a transaction dated Thursday, January 29th. The shares were sold at an average price of $122.04, for a total value of $51,867.00. Following the completion of the sale, the chief operating officer owned 2,758 shares of the company’s stock, valued at $336,586.32. This represents a 13.35% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Palomar Stock Up 0.5%

Shares of PLMR stock opened at $124.22 on Tuesday. Palomar Holdings, Inc. has a 12 month low of $104.47 and a 12 month high of $175.85. The firm has a market cap of $3.29 billion, a PE ratio of 19.38 and a beta of 0.44. The company’s fifty day simple moving average is $127.67 and its 200-day simple moving average is $123.57.

Palomar (NASDAQ:PLMR) last issued its quarterly earnings data on Thursday, November 6th. The company reported $2.01 EPS for the quarter, beating analysts’ consensus estimates of $1.56 by $0.45. Palomar had a return on equity of 21.93% and a net margin of 22.59%.The firm had revenue of $244.66 million for the quarter, compared to analyst estimates of $207.98 million. During the same period in the prior year, the firm posted $1.23 EPS. On average, equities analysts predict that Palomar Holdings, Inc. will post 5.99 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of PLMR. Osaic Holdings Inc. raised its position in shares of Palomar by 93.7% during the second quarter. Osaic Holdings Inc. now owns 19,370 shares of the company’s stock worth $2,933,000 after acquiring an additional 9,371 shares during the last quarter. Campbell & CO Investment Adviser LLC acquired a new stake in Palomar in the third quarter worth about $1,459,000. Sumitomo Mitsui Trust Group Inc. raised its holdings in Palomar by 11.1% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 456,172 shares of the company’s stock worth $53,258,000 after purchasing an additional 45,665 shares during the last quarter. Y Intercept Hong Kong Ltd lifted its position in Palomar by 434.6% during the 3rd quarter. Y Intercept Hong Kong Ltd now owns 36,496 shares of the company’s stock valued at $4,261,000 after purchasing an additional 29,669 shares during the period. Finally, Hussman Strategic Advisors Inc. bought a new position in shares of Palomar in the 3rd quarter valued at about $2,452,000. Hedge funds and other institutional investors own 90.25% of the company’s stock.

Key Palomar News

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Palomar closed the acquisition of The Gray Casualty & Surety Company, expanding its surety capabilities and product mix — a strategic tuck‑in that can add premium, diversify risk exposure and support growth in specialty lines. BCP Completes Sale of The Gray Casualty & Surety Company
• Neutral Sentiment: Palomar will report Q4 and full‑year 2025 results after the close on Feb 11, 2026, with a conference call Feb 12 — an event that typically drives short‑term volume and volatility as investors update estimates and listen for management commentary on reserve development, underwriting margin, and growth. Earnings Release & Conference Call
• Negative Sentiment: Multiple insiders (including the CEO, President, CFO and other senior executives) sold shares on Jan. 29 and Jan. 31, reducing positions by low-single-digit percentages in many cases. Heavy insider selling can signal liquidity taking or tax/comp planning, but it may concern some investors about insider confidence or timing ahead of earnings. Representative coverage of recent insider sales is here. CEO Sells Stock (Example)

Analyst Ratings Changes

Several equities analysts recently commented on the company. Weiss Ratings upgraded Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, January 14th. Keefe, Bruyette & Woods lifted their price target on shares of Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a research report on Tuesday, January 6th. JPMorgan Chase & Co. boosted their target price on shares of Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a research note on Wednesday, January 7th. Finally, Wall Street Zen upgraded Palomar from a “hold” rating to a “buy” rating in a research report on Saturday, January 10th. Six equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $159.50.

Palomar Company Profile

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.